BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = '5-hydroxytryptamine receptor 2C' and Ligand = 'BDBM472988'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
5-hydroxytryptamine receptor 2C


(Homo sapiens (Human))
BDBM472988
PNG
((R)-4-ethyl-3-propyl-6,6a,7,8,9,10-hexahydro-5H- p...)
Show SMILES CCCc1cnc2N3CCNC[C@H]3CCc2c1CC |r|
Show InChI InChI=1S/C16H25N3/c1-3-5-12-10-18-16-15(14(12)4-2)7-6-13-11-17-8-9-19(13)16/h10,13,17H,3-9,11H2,1-2H3/t13-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
2.14n/an/an/an/an/an/an/an/a



Arena Pharmaceuticals, Inc.

US Patent


Assay Description
Radioligand binding assays were performed using the commercially available 5-HT2 receptor agonist [125I]DOI as the radioligand and nonspecific bindin...


US Patent US10836764 (2020)


BindingDB Entry DOI: 10.7270/Q22N55CP
More data for this
Ligand-Target Pair